Why would an antibiotic be listed with unclear efficacy?

Unclear efficacy means there is not enough reliable evidence to say with confidence that the antibiotic will work for the organism and infection shown on the report.

Is that the same as susceptible or resistant?

No. Susceptibility describes how an organism responds under the conditions of a laboratory test. Clinical efficacy also depends on whether the drug reaches the infection site, whether an effective dose and duration are known, and whether clinical evidence supports using it for that diagnosis.

Why might efficacy be unclear?

Clinical studies may be limited or conflicting, laboratory (in vitro) activity may not be backed by clinical outcomes, the drug may have variable activity, or the proposed use may be uncommon or outside an FDA-approved indication. Site penetration, dosing, resistance mechanisms, and patient-specific factors can also create uncertainty.

Does unclear efficacy mean the drug is recommended?

No. It is a signal to review the evidence carefully and consider better-supported alternatives. OneChoice Plus provides the rationale and references when available. An infectious-disease or pharmacy consultation may also be helpful.

See also Why would a report show an undefined dose or duration?